Search results

The Minerals consultancy group at ANSTO has expertise in chemical engineering, metallurgy, mineralogy, chemistry, geology, and radiation safety. We can support our client's project by providing process development services, technical review, and research.

Two startups supported by the nandin Innovation Centre at ANSTO have hit the ground running in 2021 securing major opportunities from state governments to see their businesses thrive.

Read about an ANSTO scientist and their work to prepare for a school project or interview.

Radioactive phosphorous for implantable medical device to treat pancreatic cancer in global clinical trial

Australia’s Open Pool Australian Lightwater (OPAL) reactor is a state-of-the-art 20 megawatt multi-purpose reactor that uses low enriched uranium (LEU) fuel to achieve a range of  activities to benefit human health, enable research to support a more sustainable environment and provide innovative solutions for industry.

Innovative medical device Rhenium-SCT® therapy for non-melanoma skin cancer is now available in Australia

January 2021 saw the arrival of four shipping containers of radiation safety hutch panels for the first new Bright beamline, Micro-Computed Tomography (MCT). Installation commenced shortly thereafter with the manufacturer, Caratelli SAS, working in conjunction with Victorian-based company, Lycopodium Limited.

The Medium Energy- X-ray Absorption Spectroscopy beamlines will provide access to XANES and EXAFS data from a bending magnet source, optimised for cutting-edge applications in biological, agricultural and environmental science in an energy range that is not currently available at the Australia Synchrotron.

Airbus Australia Pacific has provided students participating in ANSTO’s National Graduate Innovation Forum with a practical challenge relating to technology that is exposed to damaging radiation in space.

ANSTO has a range of capabilities and expertise to support aerospace and space research.

The 2023 Australian Synchrotron Stephen Wilkins Thesis Medal has been awarded to Dr Yanxiang Meng from the Walter & Eliza Hall Institute for Medical Research and the University of Melbourne for his research investigating the molecular mechanism at work in a form of programmed cell death, which is implicated in a variety of inflammatory diseases.

Be the first to find out the latest news regarding nuclear science and technology products, services, and innovation.

On behalf of ANSTO thank you for your interest in our tours. We hope your visit to ANSTO will be both enjoyable and informative.

Frequently Asked Questions on the Macromolecular Crystallography beamlines (MX1 and MX2)

Dr Anne Hellstedt has been appointed Director of ANSTO’s Innovation Precinct.

The nandin Deep Technology Incubator at ANSTO’s Lucas Heights innovation precinct has welcomed two new members.